Devin Wigington

Devin Wigington is responsible for overseeing all aspects of the analytical and microbiology Quality Control laboratories. Devin has more than 19 years of quality control experience within the pharmaceutical and biotechnology industries. During his career, he has managed groups responsible for testing at all stages. This includes development of methods to support preclinical studies, preparing methods for early stage cGMP manufacturing, method validation, and release testing of commercial products.

Prior to joining Berkshire Sterile Manufacturing Devin previously oversaw Quality Control and Analytical Methods Development groups at VaxInnate. Devin was responsible for the development of methods for preclinical work to Phase I cGMP manufacturing. Before VaxInnate, Devin supervised and managed Quality Control departments that supported commercial products at both ImClone (later Eli Lilly) and Enzon Pharmaceuticals. Devin started his career working for the GMP manufacturing service provider Chesapeake Biological Laboratories (now Emergent BioSolutions). He became the Quality Control Supervisor before leaving for graduate school.

Devin has an MS in Analytical Chemistry from the University of Maryland, Baltimore County (UMBC) and a BS in Chemistry from Mount Saint Mary’s College.